Prediction of single‐nucleotide substitutions that result in exon skipping: identification of a splicing silencer in BRCA1 exon 6

Missense, nonsense, and translationally silent mutations can inactivate genes by altering the inclusion of mutant exons in mRNA, but their overall frequency among disease‐causing exonic substitutions is unknown. Here, we have tested missense and silent mutations deposited in the BRCA1 mutation databases of unclassified variants for their effects on exon inclusion. Analysis of 21 BRCA1 variants using minigene assays revealed a single exon‐skipping mutation c.231G>T. Comprehensive mutagenesis of an adjacent 12‐nt segment showed that this silent mutation resulted in a higher level of exon skipping than the 35 other single‐nucleotide substitutions. Exon inclusion levels of mutant constructs correlated significantly with predicted splicing enhancers/silencers, prompting the development of two online utilities freely available at http://www.dbass.org.uk. EX‐SKIP quickly estimates which allele is more susceptible to exon skipping, whereas HOT‐SKIP examines all possible mutations at each exon position and identifies candidate exon‐skipping positions/substitutions. We demonstrate that the distribution of exon‐skipping and disease‐associated substitutions previously identified in coding regions was biased toward top‐ranking HOT‐SKIP mutations. Finally, we show that proteins 9G8, SC35, SF2/ASF, Tra2, and hnRNP A1 were associated with significant alterations of BRCA1 exon 6 inclusion in the mRNA. Together, these results facilitate prediction of exonic substitutions that reduce exon inclusion in mature transcripts. Hum Mutat 32:1–9, 2011. © 2011 Wiley‐Liss, Inc.

[1]  G. Sarkar,et al.  The "megaprimer" method of site-directed mutagenesis. , 1990, BioTechniques.

[2]  N L Harris,et al.  Splice junctions, branch point sites, and exons: sequence statistics, identification, and applications to genome project. , 1990, Methods in enzymology.

[3]  J. Lavergne,et al.  Human Gene Mutation , 1994 .

[4]  Oliver Mühlemann,et al.  Inhibition by SR proteins of splicing of a regulated adenovirus pre-mRNA , 1996, Nature.

[5]  A. Aguzzi,et al.  Adenosine deaminase deficiency in adults. , 1997, Blood.

[6]  Michael R. Green,et al.  Targeting of U2AF65 to Sites of Active Splicing in the Nucleus , 1997, The Journal of cell biology.

[7]  T. Cooper,et al.  The regulation of splice-site selection, and its role in human disease. , 1997, American journal of human genetics.

[8]  B. Koller,et al.  BRCA1 required for transcription-coupled repair of oxidative DNA damage. , 1998, Science.

[9]  C. R. Valentine,et al.  The association of nonsense codons with exon skipping. , 1998, Mutation research.

[10]  G M Lenoir,et al.  A BRCA1 nonsense mutation causes exon skipping. , 1998, American journal of human genetics.

[11]  Sara G. Becker-Catania,et al.  Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences. , 1999, American journal of human genetics.

[12]  Michael R. Green,et al.  Functional recognition of the 3′ splice site AG by the splicing factor U2AF35 , 1999, Nature.

[13]  Michael Q. Zhang,et al.  Exonic Splicing Enhancer Motif Recognized by Human SC35 under Splicing Conditions , 2000, Molecular and Cellular Biology.

[14]  C. Lorson,et al.  An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN. , 2000, Human molecular genetics.

[15]  X. Estivill,et al.  Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. , 2000, Human molecular genetics.

[16]  Michael Q. Zhang,et al.  A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes , 2001, Nature Genetics.

[17]  S. Lipkin,et al.  A nonsense mutation in MLH1 causes exon skipping in three unrelated HNPCC families. , 2001, Cancer research.

[18]  Olufunmilayo I Olopade,et al.  BRCA2 T2722R is a deleterious allele that causes exon skipping. , 2002, American journal of human genetics.

[19]  R. Desnick,et al.  Alternative splicing in the alpha-galactosidase A gene: increased exon inclusion results in the Fabry cardiac phenotype. , 2002, American journal of human genetics.

[20]  A. Krainer,et al.  Listening to silence and understanding nonsense: exonic mutations that affect splicing , 2002, Nature Reviews Genetics.

[21]  Jinhua Wang,et al.  ESEfinder: a web resource to identify exonic splicing enhancers , 2003, Nucleic Acids Res..

[22]  M. King,et al.  Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2 , 2003, Science.

[23]  J. G. Patton,et al.  Disruption of exon definition produces a dominant-negative growth hormone isoform that causes somatotroph death and IGHD II , 2003, Human Genetics.

[24]  Teresa Casals,et al.  New type of disease causing mutations: the example of the composite exonic regulatory elements of splicing in CFTR exon 12. , 2003, Human molecular genetics.

[25]  Christopher B. Burge,et al.  Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals , 2003, RECOMB '03.

[26]  Gene W. Yeo,et al.  Systematic Identification and Analysis of Exonic Splicing Silencers , 2004, Cell.

[27]  J. Královičová,et al.  Branch site haplotypes that control alternative splicing. , 2004, Human molecular genetics.

[28]  Christopher B. Burge,et al.  RESCUE-ESE identifies candidate exonic splicing enhancers in vertebrate exons , 2004, Nucleic Acids Res..

[29]  L. Chasin,et al.  Computational definition of sequence motifs governing constitutive exon splicing. , 2004, Genes & development.

[30]  D. Turner,et al.  Incorporating chemical modification constraints into a dynamic programming algorithm for prediction of RNA secondary structure. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[31]  I. Vořechovský,et al.  Identification of Splicing Silencers and Enhancers in Sense Alus: a Role for Pseudoacceptors in Splice Site Repression , 2005, Molecular and Cellular Biology.

[32]  M. Raponi,et al.  Synonymous mutations in CFTR exon 12 affect splicing and are not neutral in evolution. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Ellis,et al.  Multiple roles of arginine/serine-rich splicing factors in RNA processing. , 2005, Biochemical Society transactions.

[34]  G. Ast,et al.  Human-mouse comparative analysis reveals that branch-site plasticity contributes to splicing regulation. , 2005, Human molecular genetics.

[35]  Leandro Quadrana,et al.  Concerted regulation of nuclear and cytoplasmic activities of SR proteins by AKT , 2005, Nature Structural &Molecular Biology.

[36]  G. Guanti,et al.  In silico and in vivo splicing analysis of MLH1 and MSH2 missense mutations shows exon- and tissue-specific effects , 2006, BMC Genomics.

[37]  Gene W. Yeo,et al.  Inference of Splicing Regulatory Activities by Sequence Neighborhood Analysis , 2006, PLoS genetics.

[38]  G. Ast,et al.  Comparative analysis identifies exonic splicing regulatory sequences--The complex definition of enhancers and silencers. , 2006, Molecular cell.

[39]  Michael Q. Zhang,et al.  An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers. , 2006, Human molecular genetics.

[40]  S. Brennan,et al.  An intronic mutation within FGB (IVS1+2076 a→g) is associated with afibrinogenemia and recurrent transient ischemic attacks , 2006, Journal of thrombosis and haemostasis : JTH.

[41]  Zefeng Wang,et al.  General and specific functions of exonic splicing silencers in splicing control. , 2006, Molecular cell.

[42]  W. Foulkes,et al.  Disruption of an exon splicing enhancer in exon 3 of MLH1 is the cause of HNPCC in a Quebec family , 2005, Journal of Medical Genetics.

[43]  Qing Wang,et al.  Systematic mRNA analysis for the effect of MLH1 and MSH2 missense and silent mutations on aberrant splicing , 2006, Human mutation.

[44]  Francisco E. Baralle,et al.  Reduced splicing efficiency induced by synonymous substitutions may generate a substrate for natural selection of new splicing isoforms: the case of CFTR exon 12 , 2006, Nucleic acids research.

[45]  Rolf Backofen,et al.  Pre-mRNA Secondary Structures Influence Exon Recognition , 2007, PLoS genetics.

[46]  J. Královičová,et al.  Global control of aberrant splice-site activation by auxiliary splicing sequences: evidence for a gradient in exon and intron definition , 2007, Nucleic acids research.

[47]  C. Lázaro,et al.  Nature and mRNA effect of 282 different NF1 point mutations: focus on splicing alterations , 2008, Human mutation.

[48]  Marco Baralle,et al.  The pathological splicing mutation c.6792C > G in NF1 exon 37 causes a change of tenancy between antagonistic splicing factors , 2008, FEBS letters.

[49]  J. Tazi,et al.  A large fraction of unclassified variants of the mismatch repair genes MLH1 and MSH2 is associated with splicing defects , 2008, Human mutation.

[50]  Michael Q. Zhang,et al.  RNA landscape of evolution for optimal exon and intron discrimination , 2008, Proceedings of the National Academy of Sciences.

[51]  R. Lidereau,et al.  Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene , 2008, Journal of Medical Genetics.

[52]  Jan Komorowski,et al.  Nucleosomes are well positioned in exons and carry characteristic histone modifications. , 2009, Genome research.

[53]  M. Alló,et al.  Neuronal cell depolarization induces intragenic chromatin modifications affecting NCAM alternative splicing , 2009, Proceedings of the National Academy of Sciences.

[54]  Noah Spies,et al.  Biased chromatin signatures around polyadenylation sites and exons. , 2009, Molecular cell.

[55]  Igor Vorechovsky,et al.  Transposable elements in disease-associated cryptic exons , 2010, Human Genetics.

[56]  P. Stenson,et al.  The Human Gene Mutation Database: 2008 update , 2009, Genome Medicine.

[57]  Schraga Schwartz,et al.  SROOGLE: webserver for integrative, user-friendly visualization of splicing signals , 2009, Nucleic Acids Res..

[58]  A. Spurdle,et al.  Effect of BRCA2 sequence variants predicted to disrupt exonic splice enhancers on BRCA2 transcripts , 2010, BMC Medical Genetics.

[59]  J. Ahringer,et al.  Differential chromatin marking of introns and expressed exons by H3K36me3 , 2008, Nature Genetics.

[60]  B. Blencowe,et al.  When chromatin meets splicing , 2009, Nature Structural &Molecular Biology.

[61]  Joonhee Han,et al.  SR proteins in vertical integration of gene expression from transcription to RNA processing to translation. , 2009, Molecular cell.

[62]  Christoforos Nikolaou,et al.  Nucleosome positioning as a determinant of exon recognition , 2009, Nature Structural &Molecular Biology.

[63]  Francesco Piva,et al.  SpliceAid: a database of experimental RNA target motifs bound by splicing proteins in humans , 2009, Bioinform..

[64]  Lili Wan,et al.  RNA and Disease , 2009, Cell.

[65]  Petr Divina,et al.  Ab initio prediction of mutation-induced cryptic splice-site activation and exon skipping , 2009, European Journal of Human Genetics.

[66]  C. Toulas,et al.  The c.5242C>A BRCA1 missense variant induces exon skipping by increasing splicing repressors binding , 2010, Breast Cancer Research and Treatment.

[67]  F. Pagani,et al.  A High Proportion of DNA Variants of BRCA1 and BRCA2 Is Associated with Aberrant Splicing in Breast/Ovarian Cancer Patients , 2010, Clinical Cancer Research.

[68]  I. Bièche,et al.  A missense variant within BRCA1 exon 23 causing exon skipping. , 2010, Cancer genetics and cytogenetics.

[69]  J. Královičová,et al.  Allele-specific recognition of the 3′ splice site of INS intron 1 , 2010, Human Genetics.

[70]  T. Frebourg,et al.  The BRCA1 c.5434C→G (p.Pro1812Ala) variant induces a deleterious exon 23 skipping by affecting exonic splicing regulatory elements , 2010, Journal of Medical Genetics.

[71]  R. Amann,et al.  Predictive Identification of Exonic Splicing Enhancers in Human Genes , 2022 .